Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $893.33 million. The enterprise value is $343.37 million.

Market Cap	893.33M
Enterprise Value	343.37M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 342.27 million shares outstanding. The number of shares has increased by 43.14% in one year.

Current Share Class	341.27M
Shares Outstanding	342.27M
Shares Change (YoY)	+43.14%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	24.91%
Owned by Institutions (%)	57.45%
Float	231.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	58.67
Forward PS	30.58
PB Ratio	2.40
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	23.92
EV / EBITDA	1.70
EV / EBIT	1.71
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.39, with a Debt / Equity ratio of 0.15.

Current Ratio	9.39
Quick Ratio	9.26
Debt / Equity	0.15
Debt / EBITDA	0.28
Debt / FCF	n/a
Interest Coverage	293.03

Financial Efficiency

Return on equity (ROE) is -44.84% and return on invested capital (ROIC) is 25.63%.

Return on Equity (ROE)	-44.84%
Return on Assets (ROA)	20.17%
Return on Invested Capital (ROIC)	25.63%
Return on Capital Employed (ROCE)	34.51%
Revenue Per Employee	$65,250
Profits Per Employee	-$922,264
Employee Count	220
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.45% in the last 52 weeks. The beta is 1.35, so Nuvation Bio's price volatility has been higher than the market average.

Beta (5Y)	1.35
52-Week Price Change	-7.45%
50-Day Moving Average	2.22
200-Day Moving Average	2.31
Relative Strength Index (RSI)	63.75
Average Volume (20 Days)	4,489,046

Short Selling Information

The latest short interest is 69.82 million, so 20.40% of the outstanding shares have been sold short.

Short Interest	69.82M
Short Previous Month	65.75M
Short % of Shares Out	20.40%
Short % of Float	30.22%
Short Ratio (days to cover)	13.33

Income Statement

In the last 12 months, Nuvation Bio had revenue of $14.36 million and -$202.90 million in losses. Loss per share was -$0.63.

Revenue	14.36M
Gross Profit	3.95M
Operating Income	200.43M
Pretax Income	-510.72M
Net Income	-202.90M
EBITDA	201.48M
EBIT	200.43M
Loss Per Share	-$0.63

Full Income Statement

Balance Sheet

The company has $607.72 million in cash and $57.76 million in debt, giving a net cash position of $549.96 million or $1.61 per share.

Cash & Cash Equivalents	607.72M
Total Debt	57.76M
Net Cash	549.96M
Net Cash Per Share	$1.61
Equity (Book Value)	372.91M
Book Value Per Share	1.09
Working Capital	556.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$168.19 million and capital expenditures -$388,000, giving a free cash flow of -$168.58 million.

Operating Cash Flow	-168.19M
Capital Expenditures	-388,000
Free Cash Flow	-168.58M
FCF Per Share	-$0.49

Full Cash Flow Statement

Margins

Gross Margin	27.54%
Operating Margin	1,396.27%
Pretax Margin	-1,413.43%
Profit Margin	n/a
EBITDA Margin	1,403.56%
EBIT Margin	1,396.27%
FCF Margin	n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.14%
Shareholder Yield	-43.14%
Earnings Yield	-22.71%
FCF Yield	-18.87%

Analyst Forecast

The average price target for Nuvation Bio is $8.00, which is 206.51% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	206.51%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nuvation Bio has an Altman Z-Score of 1.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.6
Piotroski F-Score	4